$10.17
0.10.99%
Ult. Agg.: Oct 20, 12:54 PM
$10.10
0.030.3%
Ginkgo Bioworks Holdings (DNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ginkgo Bioworks Holdings (DNA) ha pubblicato l'ultima guidance il novembre 6, 2025 per fiscal year 2025. La società ha previsto un fatturato pari a $167M - $187M per il periodo.
Rispetto alle previsioni precedenti, Ginkgo Bioworks Holdings ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Ginkgo Bioworks Holdings ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Ginkgo Bioworks Holdings. 13
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.70 | $-1.34 | $-1.39 | $-1.24 |
| Actual | $-0.92 | $-1.39 | $-1.41 | $-1.45 |
| Surprise | -31.4% | -3.73% | -1.44% | -16.9% |
| Revenue | ||||
| Estimate | $24.8M | $42.4M | $37.3M | $39.0M |
| Actual | $20.2M | $19.5M | $33.3M | $38.8M |
| Surprise | -18.6% | -54.0% | -10.8% | -0.33% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.55 | $-0.82 |
| Revenue | ||
| Consensus | $21.3M | $23.5M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.92 | $-0.70 | -31.4 % |
| Q1 | May 7, 2026 | $-1.39 | $-1.34 | -3.73 % |
| Q4 | Feb 26, 2026 | $-1.41 | $-1.39 | -1.44 % |
| Q3 | Nov 6, 2025 | $-1.45 | $-1.24 | -16.9 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $20.16M | $24.76M | -18.6 % |
| Q1 | May 7, 2026 | $19.47M | $42.37M | -54.0 % |
| Q4 | Feb 26, 2026 | $33.32M | $37.34M | -10.8 % |
| Q3 | Nov 6, 2025 | $38.84M | $38.97M | -0.33 % |